Numeric Investors’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$5.85M Buy
125,800
+115,900
+1,171% +$4.88M 0.04% 387
2017
Q3
$400K Buy
+9,900
New +$358K ﹤0.01% 919
2017
Q1
Sell
-13,500
Closed -$443K 1044
2016
Q4
$443K Sell
13,500
-90,300
-87% -$2.71M ﹤0.01% 850
2016
Q3
$3.27M Sell
103,800
-279,017
-73% -$8.11M 0.03% 386
2016
Q2
$10.8M Buy
+382,817
New +$15M 0.1% 204
2016
Q1
Sell
-223,404
Closed -$8.94M 1017
2015
Q4
$8.94M Buy
223,404
+121,704
+120% +$4.24M 0.1% 208
2015
Q3
$2.9M Sell
101,700
-45,152
-31% -$1.49M 0.03% 330
2015
Q2
$4.84M Sell
146,852
-155,133
-51% -$4.81M 0.06% 260
2015
Q1
$8.69M Buy
+301,985
New +$8.66M 0.11% 193
2014
Q3
Sell
-636,759
Closed -$14.3M 848
2014
Q2
$14.3M Buy
636,759
+17,900
+3% +$417K 0.21% 120
2014
Q1
$15.6M Buy
618,859
+425,342
+220% +$10.7M 0.27% 93
2013
Q4
$4.45M Buy
193,517
+56,082
+41% +$1.17M 0.07% 233
2013
Q3
$2.62M Buy
137,435
+96,508
+236% +$1.72M 0.05% 300
2013
Q2
$590K Buy
+40,927
New +$593K 0.01% 496

Other funds holding EBS

Numeric Investors's EBS Position: Q4 2017 in Review

Numeric Investors increased its Emergent Biosolutions (EBS) stake by 1,171% in Q4 2017, buying an estimated $4.88M and bringing the position to 125,800 shares worth $5.85M. The position accounts for 0.04% of the portfolio, ranked #387.

Numeric Investors first reported a position in EBS in Q2 2013 and has held it in 14 quarters since. The position peaked at $15.6M in Q1 2014. 238 funds tracked by Wall St. Rank hold EBS as of Q4 2017.

  • Numeric Investors held 125,800 shares of Emergent Biosolutions worth $5.85M as of Q4 2017.
  • Numeric Investors bought 115,900 Emergent Biosolutions shares in Q4 2017, an estimated $4.88M.
  • Emergent Biosolutions made up 0.04% of Numeric Investors's portfolio in Q4 2017, its #387 holding.
  • Numeric Investors first reported a position in Emergent Biosolutions in Q2 2013 and has held it in 14 quarters since.
  • Numeric Investors's Emergent Biosolutions position peaked at $15.6M in Q1 2014.
  • 238 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.